Literature DB >> 16195694

Use of dietary supplements containing folic acid among women of childbearing age--United States, 2005.

.   

Abstract

Neural tube defects (NTDs) are serious birth defects of the spine (spina bifida) and brain (anencephaly), affecting approximately 3,000 pregnancies each year in the United States. Daily periconceptional consumption of 400 mug of folic acid, as recommended by the Public Health Service (PHS) since 1992, reduces the occurrence of NTDs by 50%-70%. The Food and Drug Administration ordered mandatory fortification with folic acid of U.S. cereal grain products, beginning in 1998. However, despite a 26% reduction in NTDs, not all women of childbearing age receive adequate levels of folic acid from their diets. Therefore, increasing the number of women who take dietary supplements containing 400 mug of folic acid daily remains an important component of NTD prevention. This report summarizes results from the 2005 March of Dimes Gallup survey, which determined a decrease in the proportion of childbearing-aged women who reported taking folic acid in dietary supplements daily, from 40% in 2004 to 33% in 2005, returning to a level consistent with that reported during 1995-2003. These results emphasize the need for innovative programs to increase folic acid consumption to further reduce NTDs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195694

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  13 in total

1.  Theory of planned behavior and multivitamin supplement use in Caucasian college females.

Authors:  Roman Pawlak; Denise Brown; Mary Kay Meyer; Carol Connell; Kathleen Yadrick; J T Johnson; Ann Blackwell
Journal:  J Prim Prev       Date:  2008-01

2.  Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism.

Authors:  Rebecca J Schmidt; Robin L Hansen; Jaana Hartiala; Hooman Allayee; Linda C Schmidt; Daniel J Tancredi; Flora Tassone; Irva Hertz-Picciotto
Journal:  Epidemiology       Date:  2011-07       Impact factor: 4.822

3.  Clinical profile of neural tube defects in Sudanese children: Is malaria a risk factor?

Authors:  Basma Sadik; Haydar E Babikir; Mohammed A R Arbab
Journal:  Sudan J Paediatr       Date:  2017

Review 4.  Use of dietary supplements by pregnant and lactating women in North America.

Authors:  Mary Frances Picciano; Michelle K McGuire
Journal:  Am J Clin Nutr       Date:  2008-12-10       Impact factor: 7.045

5.  Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States.

Authors:  Bridget S Mosley; Mario A Cleves; Anna Maria Siega-Riz; Gary M Shaw; Mark A Canfield; D Kim Waller; Martha M Werler; Charlotte A Hobbs
Journal:  Am J Epidemiol       Date:  2008-10-25       Impact factor: 4.897

6.  Predictors of multivitamin use during pregnancy in Brazil.

Authors:  George L Wehby; Eduardo E Castilla; Jorge S Lopez-Camelo; Jeffrey C Murray
Journal:  Int J Public Health       Date:  2009       Impact factor: 3.380

7.  Assessing awareness, knowledge and use of folic acid in Kansas women between the ages of 18 and 44 years.

Authors:  Glynda F Sharp; Lorenda A Naylor; Jinwen Cai; Melissa L Hyder; Pradeep Chandra; V James Guillory
Journal:  Matern Child Health J       Date:  2008-09-23

8.  Evaluation of educational materials from a social marketing campaign to promote folic acid use among Hispanic women: insight from Cuban and Puerto Rican ethnic subgroups.

Authors:  Gwendolyn P Quinn; Kamilah B Thomas; Kimberlea Hauser; Nydia Y Rodríguez; Nazach Rodriguez-Snapp
Journal:  J Immigr Minor Health       Date:  2008-06-17

9.  Folic acid and prevention of neural tube defects.

Authors:  Milly Ryan-Harshman; Walid Aldoori
Journal:  Can Fam Physician       Date:  2008-01       Impact factor: 3.275

10.  Folate during reproduction: the Canadian experience with folic acid fortification.

Authors:  Gillian Lindzon; Deborah L O'Connor
Journal:  Nutr Res Pract       Date:  2007-09-30       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.